PET Total Lesion Glycolysis (TLG)
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰.۱ — حداکثر ۱۰۰
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low TLG0–100
- Moderate TLG100–500
- High TLG≥ 500
The PET Total Lesion Glycolysis (TLG) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include metabolic tumor volume. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Total lesion glycolysis: metabolic tumor volume multiplied by mean SUV. Prognostic PET metric in oncology.
Clinical Indication
The PET Total Lesion Glycolysis (TLG) is indicated for bedside clinical practice to support Total lesion glycolysis: metabolic tumor volume multiplied by mean SUV. Prognostic PET metric in oncology.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.
TLG = Metabolic Tumor Volume (mL) x SUVmean
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| metabolic_tumor_volume | float | Yes | Metabolic tumor volume(mL) |
| suv_mean | float | Yes | Mean standardized uptake value |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–100 | Low TLG | Relatively low total lesion glycolysis |
| 100–500 | Moderate TLG | Moderate total lesion glycolysis |
| ≥ 500 | High TLG | High total lesion glycolysis |
Evidence-Based References (EBM)
- Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. Clin Positron Imaging. 1999;2(3):159-171.